Clinical Trials Directory

Trials / Completed

CompletedNCT05837754

A Study to Assess the Gut Health Effects of Oil Compound on Healthy Adults

A Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Assess the Gut Health Effects of Oil Compound on Healthy Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Vedic Lifesciences Pvt. Ltd. · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The present study is a randomized, placebo-controlled, double-blind, parallel group study to assess the gut health effects of IP as compared to a placebo in normal, overweight and obese individuals experiencing gut issues. Approximately 94 will be randomized into 1:1 ratio to either receive IP or Placebo.

Conditions

Interventions

TypeNameDescription
OTHERC8-C125-15mL (one teaspoon to one tablespoon) once or twice a day. The participants will be dispensed a 5 ml pipette for consuming the IP.
OTHERPlacebo5-15mL (one teaspoon to one tablespoon) once or twice a day. The participants will be dispensed a 5 ml pipette for consuming the IP.

Timeline

Start date
2023-04-04
Primary completion
2024-03-20
Completion
2024-03-20
First posted
2023-05-01
Last updated
2024-04-15

Locations

7 sites across 1 country: India

Source: ClinicalTrials.gov record NCT05837754. Inclusion in this directory is not an endorsement.

A Study to Assess the Gut Health Effects of Oil Compound on Healthy Adults (NCT05837754) · Clinical Trials Directory